VC
GILD icon

Veracity Capital’s Gilead Sciences GILD Stock Holding History

Veracity Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-15,700
Closed -$1.21M – 225
2020
Q2 		$1.21M Sell
15,700
-24,500
-61% -$1.88M 0.7% 38
2020
Q1 		$3M Buy
+40,200
New +$2.78M 0.87% 25

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Veracity Capital's GILD Position: Q2 2026 in Review

Veracity Capital increased its Gilead Sciences (GILD) stake by 10% in Q2 2026, buying an estimated $93.7K and bringing the position to 7,784 shares worth $983K. The position accounts for 0.27% of the portfolio, ranked #76.

Veracity Capital first reported a position in GILD in Q1 2020 and has held it in 11 quarters since. The position peaked at $986K in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Veracity Capital held 7,784 shares of Gilead Sciences worth $983K as of Q2 2026.
  • Veracity Capital bought 711 Gilead Sciences shares in Q2 2026, an estimated $93.7K.
  • Gilead Sciences made up 0.27% of Veracity Capital's portfolio in Q2 2026, its #76 holding.
  • Veracity Capital first reported a position in Gilead Sciences in Q1 2020 and has held it in 11 quarters since.
  • Veracity Capital's Gilead Sciences position peaked at $986K in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Veracity Capital's 13F filing for Q2 2026, filed 13 Jul 2026.